Cardiol Therapeutics Inc CRDL

Primary Symbol: T.CRDL Alternate Symbol(s): T.CRDL.W.A

Healthcare

Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.

TSX:CRDL - Post by User

Cardiol Therapeutics Inc > Geez

<< Previous

Bullboard Posts

Next >>

Comment by Bullknit101on Mar 05, 2022 8:44am

166 Views

Post# 34486389

RE:Geez

There a no posts because there is nothing here to see. I'm tired of seeing pumping and people losing lots of money, it's depressing. This company was pumped this summer and then when people got excited, they issued 50M shares which drove the share price lower. Just look at the history of Vasogen. Go ahead and invest. I'm not getting burned ever again.

<< Previous

Bullboard Posts

Next >>

This company starts production at what could be Canada’s next great gold mine